PL EN
Home About us     History     Mission and Values     Management     Annual reports     Research and Development Therapeutic areas      Respiratory      Neonatology      Transplantology      Rare diseases Anti-corruption policy Products ToTylkoAstma.pl Social responsibility     Business responsibility     Ethics     Transparency     Chiesi Foundation     Patient organization support ToTylkoPochp.pl News Career Contact     Office     Adverse drug reactions     Complaints
  • Home
  • |
  • Anti-corruption policy
  • |
  • ToTylkoAstma.pl
  • |
  • ToTylkoPochp.pl
  • |
  • Registration
  • Chiesi Group
  • PL
  • EN
Welcome to Chiesi
Poland
Enter at least 3 characters
  • About us
    • History
    • Mission and Values
    • Management
    • Annual reports
    • Research and Development
  • Therapeutic areas
    • Respiratory
    • Neonatology
    • Transplantology
    • Rare diseases
  • Products
  • Social responsibility
    • Business responsibility
    • Ethics
    • Transparency
    • Chiesi Foundation
    • Patient organization support
  • News
  • Career
  • Contact
    • Office
    • Adverse drug reactions
    • Complaints
This site uses cookies. Continuing to navigate is considered accepted usage. More info CLOSE
Home page > Products

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

PRESCRIPTION DRUGS

  • A-C
  • D-F
  • G-J
  • K-M
  • N-P
  • Q-S
  • T-V
  • W-Z
  • Atimos®
    active ingredient: Formoterol
     
    Bramitob®
    active ingredient: Tobramycine
     
    Budiair®
    active ingredient: Budesonide
     
    Budiair® (Jet)
    active ingredient: Budesonide
     
    Curosurf®
    active ingredient: Poractant alfa
     
  • Envarsus®
    active ingredient Tacrolimus
     
    Flamexin®
    active ingredient Piroxicam
     
    Fostex®
    active ingredient Beclometasone + Formoterol
     
  • Holoclar®
    active ingredient Ex vivo expanded autologous human corneal epithelial cells containing stem cells
     
  • Peyona®
    active ingredient caffeine citrate
     
  • Trimbow®
    active ingredient beclomethasone dipropionate + formoterol fumarate + glycopirronyum bromide
     
© 2019 Chiesi Poland
Al. Jerozolimskie 134 02-305 Warszawa, Polska
Phone: +48 22 620 14 21
Fax: +48 22 652 37 79
info-pl@chiesi.com
  • Terms of use
  • C-share
  • Data privacy / cookies
  • Sitemap
CHIESI ON THE WEB
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
France
Chiesi S.A.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.